FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1201828006: Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4945165016 Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
4945166015 Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Is a Gliclazide and metformin only product in oral dose form true Inferred relationship Some
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet true Inferred relationship Some
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has precise active ingredient Metformin hydrochloride true Inferred relationship Some 1
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has BoSS Metformin hydrochloride true Inferred relationship Some 1
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has precise active ingredient Gliclazide true Inferred relationship Some 2
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has BoSS Gliclazide true Inferred relationship Some 2
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start